GB202009928D0 - Method - Google Patents

Method

Info

Publication number
GB202009928D0
GB202009928D0 GBGB2009928.9A GB202009928A GB202009928D0 GB 202009928 D0 GB202009928 D0 GB 202009928D0 GB 202009928 A GB202009928 A GB 202009928A GB 202009928 D0 GB202009928 D0 GB 202009928D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2009928.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freeline Therapeutics Ltd
Original Assignee
Freeline Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freeline Therapeutics Ltd filed Critical Freeline Therapeutics Ltd
Priority to GBGB2009928.9A priority Critical patent/GB202009928D0/en
Publication of GB202009928D0 publication Critical patent/GB202009928D0/en
Priority to PCT/GB2021/051654 priority patent/WO2022003349A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2009928.9A 2020-06-29 2020-06-29 Method Ceased GB202009928D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2009928.9A GB202009928D0 (en) 2020-06-29 2020-06-29 Method
PCT/GB2021/051654 WO2022003349A1 (en) 2020-06-29 2021-06-29 Method for measuring the activity of a blood clotting factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2009928.9A GB202009928D0 (en) 2020-06-29 2020-06-29 Method

Publications (1)

Publication Number Publication Date
GB202009928D0 true GB202009928D0 (en) 2020-08-12

Family

ID=71949681

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2009928.9A Ceased GB202009928D0 (en) 2020-06-29 2020-06-29 Method

Country Status (2)

Country Link
GB (1) GB202009928D0 (en)
WO (1) WO2022003349A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101258949B1 (en) * 2007-06-15 2013-04-30 재단법인 목암생명공학연구소 Method for manufacturing active recombinant blood coagulation factor ix
IL257231B (en) * 2015-08-03 2022-09-01 Bioverativ Therapeutics Inc Factor ix fusion proteins and methods of making and using same
KR102481704B1 (en) * 2016-05-16 2022-12-27 다케다 파머수티컬 컴패니 리미티드 Anti-Factor IX Padua Antibody

Also Published As

Publication number Publication date
WO2022003349A1 (en) 2022-01-06

Similar Documents

Publication Publication Date Title
GB202010104D0 (en) Method
GB202004944D0 (en) Method
GB202100827D0 (en) Method
GB202006815D0 (en) Method
GB202004863D0 (en) Method
GB202017861D0 (en) Method
GB202015993D0 (en) Method
GB202014709D0 (en) Method
GB202014432D0 (en) Method
GB202011823D0 (en) Method
GB202010922D0 (en) Method
GB202010046D0 (en) Method
GB202007044D0 (en) Method
GB202006047D0 (en) Method
GB202004515D0 (en) Method
GB202003580D0 (en) Method
GB202104130D0 (en) Method
GB202101188D0 (en) Method
GB202100365D0 (en) Method
GB202020180D0 (en) Method
GB202020183D0 (en) Method
GB202018514D0 (en) Method
GB202018262D0 (en) Method
GB202018125D0 (en) Method
GB202017725D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)